Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design
- PMID: 24402780
- DOI: 10.1002/bimj.201300012
Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design
Abstract
The Vaccine Safety Datalink project captures electronic health record data including vaccinations and medically attended adverse events on 8.8 million enrollees annually from participating managed care organizations in the United States. While the automated vaccination data are generally of high quality, a presumptive adverse event based on diagnosis codes in automated health care data may not be true (misclassification). Consequently, analyses using automated health care data can generate false positive results, where an association between the vaccine and outcome is incorrectly identified, as well as false negative findings, where a true association or signal is missed. We developed novel conditional Poisson regression models and fixed effects models that accommodate misclassification of adverse event outcome for self-controlled case series design. We conducted simulation studies to evaluate their performance in signal detection in vaccine safety hypotheses generating (screening) studies. We also reanalyzed four previously identified signals in a recent vaccine safety study using the newly proposed models. Our simulation studies demonstrated that (i) outcome misclassification resulted in both false positive and false negative signals in screening studies; (ii) the newly proposed models reduced both the rates of false positive and false negative signals. In reanalyses of four previously identified signals using the novel statistical models, the incidence rate ratio estimates and statistical significances were similar to those using conventional models and including only medical record review confirmed cases.
Keywords: Conditional Poisson model; Fixed effects model; Misclassification of adverse events; Screening studies; Self-controlled case series.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.Biom J. 2018 Jul;60(4):748-760. doi: 10.1002/bimj.201700088. Epub 2018 May 16. Biom J. 2018. PMID: 29768667 Free PMC article.
-
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112. Arch Pediatr Adolesc Med. 2011. PMID: 21810637
-
The Vaccine Safety Datalink: a model for monitoring immunization safety.Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502240 Review.
-
Mechanistic actions of the risks and adverse events associated with vaccine administration.J Allergy Clin Immunol. 2004 Nov;114(5):1010-20; quiz 1021. doi: 10.1016/j.jaci.2004.09.007. J Allergy Clin Immunol. 2004. PMID: 15536401 Review.
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
Cited by
-
Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations.Vaccine. 2019 May 31;37(25):3267-3277. doi: 10.1016/j.vaccine.2019.04.075. Epub 2019 May 6. Vaccine. 2019. PMID: 31072733 Free PMC article. Review.
-
Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.Biom J. 2018 Jul;60(4):748-760. doi: 10.1002/bimj.201700088. Epub 2018 May 16. Biom J. 2018. PMID: 29768667 Free PMC article.
-
Bias from outcome misclassification in immunization schedule safety research.Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):221-228. doi: 10.1002/pds.4374. Epub 2018 Jan 2. Pharmacoepidemiol Drug Saf. 2018. PMID: 29292551 Free PMC article.
-
Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):839-48. doi: 10.1002/pds.3618. Epub 2014 Apr 3. Pharmacoepidemiol Drug Saf. 2014. PMID: 24700557 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical